Navigation Links
Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals
Date:12/14/2010

PITTSBURGH, Dec. 14, 2010 /PRNewswire/ -- BIOSAFE, Inc. has announced that it has registered with the USEPA two new water-based antimicrobial solutions and entered into a commercialization agreement with Kentucky-based Union Springs Pharmaceuticals to market products containing BIOSAFE's patented and exclusive antimicrobial polymer, HM4100.  The unique and effective antimicrobial technology safely protects surfaces from harmful and degrading effects of bacteria, mold, mildew and fungi.  HM4100 is approved for uses in a variety of substrates, including textiles, plastics, medical goods, construction and building products, and consumer products.  This agreement gives Pittsburgh-based BIOSAFE greater access to the national and international marketplace, beginning with its first large order from Union Springs on December 6, 2010.

Union Springs offers MyClyns® (antimicrobial germ spray) and will offer products containing HM4100 under the MyClyns Antimicrobial Surface Treatments banner.  HM4100 is a residual long-term antimicrobial that has proven its effectiveness against the proliferation of such bacteria as MRSA, VREF and Staph, along with mold, mildew and some influenza A viruses that include bird flu (H5N1) and swine flue (H1N1).

Part of the significance of the BIOSAFE solution is that it can be applied to both hard and porous surfaces, from tables, desks and counters, to bedding, clothing and carpeting.

"This agreement with Union Springs Pharmaceuticals and the launch of MyClyns products featuring our patented HM4100 antimicrobial is more than just a business venture," said Max Fedor, CEO of BIOSAFE.  "The health protection benefits for millions of people around the world are potentially very significant.  Thanks to this strategic alliance with Union Springs Pharmaceuticals, we will be able to build a strong market presence around our unique technology."

Union Springs Pharmaceuticals plans to immediately market five new products containing HM4100, incorporating the antimicrobial treatment in sprays, surface wipes, fabric refreshers and as a laundry additive.  Each of the new products will be launched in the first quarter of 2011. Following these steps, Union Springs plans to market additional products treated with HM4100.

"BIOSAFE continues to explore ways for further enhance the commercialization pipeline for HM4100," said Mr. Fedor.  "The antimicrobial now has been approved by the United States EPA in both powder and liquid form, which improves scalability and distribution.  To achieve this vision, BIOSAFE will work to form new strategic partnerships to grow into new geographic and vertical industry markets."

About BIOSAFE

Pittsburgh-based BIOSAFE, Inc. has been funded by the Pittsburgh Life Sciences Greenhouse, Innovation Works, and Bluetree Allied Angels, manufactures and sells an antimicrobial polymer, HM 4100.  HM4100 is effective in defending against bacteria, fungi (mold and mildew), yeast, algae, and even certain viruses.  BIOSAFE's patented technology is an excellent antimicrobial additive for treating plastics, textiles, metals, ceramics, and activated carbon, with superior performance and economic benefits.  For further information, visit the BIOSAFE website ate www.biosafe.com

About Union Springs Pharmaceuticals

Union Springs Pharmaceuticals specializes in providing innovative personal and environmental protection products for the EMS, fire, law enforcement, corrections, military, government, healthcare and consumer markets.  Union Springs Pharmaceuticals currently markets MyClyns, the revolutionary germ protection spray that is safe to spray into the eyes, nose and mouth.  The company also offers the T-5000 Series P-95 respirators and ViralClyns N95 respirators, which are the only disposable respirators with an infused EPA-approved antimicrobial for extra protection, and ExtendaClyns, a non-alcohol based hand sanitizer, that kills 99.9 percent of germs that doesn't dry out hands and skin, and offers long-lasting effect.  More information on Union Springs Pharmaceuticals and its products can be found at www.MyClyns.com.


'/>"/>
SOURCE BIOSAFE, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
2. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
3. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
4. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
8. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
9. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
10. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
11. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
Breaking Biology News(10 mins):